[go: up one dir, main page]

FR2947551B1 - Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a)pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb) - Google Patents

Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a)pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb)

Info

Publication number
FR2947551B1
FR2947551B1 FR0903237A FR0903237A FR2947551B1 FR 2947551 B1 FR2947551 B1 FR 2947551B1 FR 0903237 A FR0903237 A FR 0903237A FR 0903237 A FR0903237 A FR 0903237A FR 2947551 B1 FR2947551 B1 FR 2947551B1
Authority
FR
France
Prior art keywords
pyrimido
pkb
pyrimidin
tetrahydro
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0903237A
Other languages
English (en)
Other versions
FR2947551A1 (fr
Inventor
Eric Bacque
Maurice Brollo
Ahmad Youssef El
Romme Bruno Filoche
Frank Halley
Andreas Karlsson
Laurent Schio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0903237A priority Critical patent/FR2947551B1/fr
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to DK10742013.5T priority patent/DK2448940T3/da
Priority to SG2011097839A priority patent/SG177464A1/en
Priority to MX2012000103A priority patent/MX2012000103A/es
Priority to HK12109830.1A priority patent/HK1169388B/xx
Priority to RU2012103477/04A priority patent/RU2561130C2/ru
Priority to MYPI2011006391A priority patent/MY155661A/en
Priority to BRPI1015943A priority patent/BRPI1015943A8/pt
Priority to PCT/FR2010/051374 priority patent/WO2011001113A2/fr
Priority to ARP100102347A priority patent/AR077363A1/es
Priority to JP2012518119A priority patent/JP5655070B2/ja
Priority to ES10742013.5T priority patent/ES2487623T3/es
Priority to EP10742013.5A priority patent/EP2448940B1/fr
Priority to SI201030717T priority patent/SI2448940T1/sl
Priority to PT107420135T priority patent/PT2448940E/pt
Priority to US13/381,790 priority patent/US8846670B2/en
Priority to CA2766909A priority patent/CA2766909C/fr
Priority to HRP20140786AT priority patent/HRP20140786T1/hr
Priority to KR1020127002806A priority patent/KR20120103553A/ko
Priority to CN201080039109.6A priority patent/CN102482286B/zh
Priority to PL10742013T priority patent/PL2448940T3/pl
Priority to SG10201403149YA priority patent/SG10201403149YA/en
Priority to AU2010267815A priority patent/AU2010267815B2/en
Priority to UY0001032754A priority patent/UY32754A/es
Priority to TW099121933A priority patent/TWI455940B/zh
Publication of FR2947551A1 publication Critical patent/FR2947551A1/fr
Priority to IL217293A priority patent/IL217293A/en
Application granted granted Critical
Publication of FR2947551B1 publication Critical patent/FR2947551B1/fr
Priority to CY20141100668T priority patent/CY1115599T1/el
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0903237A 2009-07-02 2009-07-02 Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a)pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb) Expired - Fee Related FR2947551B1 (fr)

Priority Applications (27)

Application Number Priority Date Filing Date Title
FR0903237A FR2947551B1 (fr) 2009-07-02 2009-07-02 Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a)pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb)
US13/381,790 US8846670B2 (en) 2009-07-02 2010-07-01 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
MX2012000103A MX2012000103A (es) 2009-07-02 2010-07-01 Nuevos derivados de 1,2,3,4-tetrahidro-pirimido (1,2-a) pirimidin-6-ona, su preparacion y su uso farmaceutica.
HK12109830.1A HK1169388B (en) 2009-07-02 2010-07-01 6,7,8,9-tetrahydro-pyrimido{1,2-a} pyrimidin-4-one derivatives, their preparation and pharmaceutical use thereof
RU2012103477/04A RU2561130C2 (ru) 2009-07-02 2010-07-01 НОВЫЕ ПРОИЗВОДНЫЕ 1,2,3,4-ТЕТРАГИДРОПИРИМИДО{1,2-a}ПИРИМИДИН-6-ОНА, ИХ ПОЛУЧЕНИЕ И ФАРМАЦЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ
MYPI2011006391A MY155661A (en) 2009-07-02 2010-07-01 Novel 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives, preparation thereof and pharmaceutical use thereof
BRPI1015943A BRPI1015943A8 (pt) 2009-07-02 2010-07-01 derivados de 1,2,3,4-tetra - hidro - pirimido {1,2-a} pirimidin-6-ona, o respectivo preparo e a respectiva utilização farmacêutica.
PCT/FR2010/051374 WO2011001113A2 (fr) 2009-07-02 2010-07-01 NOUVEAUX DERIVES DE 1,2,3,4-TETRAHYDRO-PYRIMIDO{1,2-a}PYRIMIDIN-6-ONE,LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE
ARP100102347A AR077363A1 (es) 2009-07-02 2010-07-01 DERIVADOS DE 1,2,3,4- TETRAHIDRO-PIRIMIDO{1,2-A} PIRIMIDIN-6-ONA, SU PREPARACIoN, SU UTILIZACIoN EN QUIMIOTERAPIA Y SUS COMPOSICIONES FARMACEUTICAS.
JP2012518119A JP5655070B2 (ja) 2009-07-02 2010-07-01 新規６，７，８，９−テトラヒドロピリミド｛１，２−ａ｝ピリミジン−４−オン誘導体、これらの調製およびこれらの医薬的使用
ES10742013.5T ES2487623T3 (es) 2009-07-02 2010-07-01 Derivados de 6,7,8,9-tetrahidro-pirimido{1,2-a}pirimidin-4-ona, su preparación y su aplicación farmacéutica
EP10742013.5A EP2448940B1 (fr) 2009-07-02 2010-07-01 Dérivés de 6,7,8,9-tétrahydro-pyrimido{1,2-a} pyrimidin-4-one, leur préparation et leur utilisation pharmaceutique
SI201030717T SI2448940T1 (sl) 2009-07-02 2010-07-01 Derivati 6,7,8,9-tetrahidro-pirimido(1,2-a)pirimidin-4-ona, njihova priprava in njihova farmacevtska uporaba
PT107420135T PT2448940E (pt) 2009-07-02 2010-07-01 Derivados de 6,7,8,9-tetra-hidro-pirimido{1,2-α} pirimidin- 4-ona, sua preparação e sua utilização farmacêutica
DK10742013.5T DK2448940T3 (da) 2009-07-02 2010-07-01 Derivater af 6,7,8,9 tetrahydro-pyrimido{1,2-a}pyrimidin-4-on, fremstilling og farmaceutisk anvendelse heraf
CN201080039109.6A CN102482286B (zh) 2009-07-02 2010-07-01 新型1,2,3,4-四氢嘧啶并{1,2-a}嘧啶-6-酮衍生物、其制备以及其医药用途
SG2011097839A SG177464A1 (en) 2009-07-02 2010-07-01 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
KR1020127002806A KR20120103553A (ko) 2009-07-02 2010-07-01 신규 １,２,３,４-테트라히드로-피리미도（１,２-ａ）피리미딘-６-온 유도체, 그의 제조법 및 그의 제약 용도
HRP20140786AT HRP20140786T1 (hr) 2009-07-02 2010-07-01 DERIVATI 6,7,8,9-TETRAHIDROPIRIMIDO[1,2-a]PIRIMIDIN-4-ONA, NJIHOVO DOBIVANJE I NJIHOVA FARMACEUTSKA UPOTREBA
PL10742013T PL2448940T3 (pl) 2009-07-02 2010-07-01 Pochodne 6,7,8,9-tetrahydro-pirymido{1,2-a} pirymidyn-4-onu, ich wytwarzanie i zastosowanie farmaceutyczne
SG10201403149YA SG10201403149YA (en) 2009-07-02 2010-07-01 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof and pharmaceutical use thereof
AU2010267815A AU2010267815B2 (en) 2009-07-02 2010-07-01 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
CA2766909A CA2766909C (fr) 2009-07-02 2010-07-01 Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one,leur preparation et leur utilisation pharmaceutique
UY0001032754A UY32754A (es) 2009-07-02 2010-07-02 NUEVOS DERIVADOS DE 1,2,3,4-TETRAHIDRO-PIRIMIDO{1,2-a}PIRIMIDIN-6-ONA, SU PREPARACIÓN Y SU UTILIZACIÓN EN FARMACÉUTICA
TW099121933A TWI455940B (zh) 2009-07-02 2010-07-02 新穎１，２，３，４－四氫嘧啶并[１，２－ａ]嘧啶－４－酮衍生物、其製備及其醫藥用途
IL217293A IL217293A (en) 2009-07-02 2011-12-29 Annotations of 9,8,7,6-tetrahydropyrimido {{a-2,1 pyramidine-4-one)
CY20141100668T CY1115599T1 (el) 2009-07-02 2014-08-20 ΠΑΡΑΓΩΓΑ ΤΗΣ 6,7,8,9-ΤΕΤΡΑΫΔΡΟ-ΠΥΡΙΜΙΔΟ{1,2-a} ΠΥΡΙΜΙΔΙΝ-4-ΟΝΗΣ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΦΑΡΜΑΚΕΥΤΙΚΗ ΤΟΥΣ ΧΡΗΣΗ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903237A FR2947551B1 (fr) 2009-07-02 2009-07-02 Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a)pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb)

Publications (2)

Publication Number Publication Date
FR2947551A1 FR2947551A1 (fr) 2011-01-07
FR2947551B1 true FR2947551B1 (fr) 2012-05-18

Family

ID=42027861

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0903237A Expired - Fee Related FR2947551B1 (fr) 2009-07-02 2009-07-02 Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a)pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb)

Country Status (1)

Country Link
FR (1) FR2947551B1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703712A1 (de) * 1977-01-29 1978-08-03 Bayer Ag Substituierte pyrimidinon eckige klammer auf (di)-thio eckige klammer zu -phosphor-(phosphon)-saeureester bzw. -esteramide, verfahren zu ihrer herstellung und ihre verwendung als insektizide, akarizide und nematizide
KR100800250B1 (ko) * 2000-09-01 2008-02-01 사노피-아벤티스 2-피리디닐-6,7,8,9-테트라히드로피리미도[1,2-α]피리미딘-4-온 및7-피리디닐-2,3-디히드로이미다조[1,2-α]피리미딘-5(1Ｈ)온유도체
CN1247585C (zh) * 2001-09-21 2006-03-29 赛诺菲安万特 取代的2－吡啶基－6,7,8,9－四氢嘧啶并[1,2－a]嘧啶－4－酮及7－吡啶基－2,3－二氢咪唑并[1,2－a]嘧啶－5(1h)酮衍生物
CA2474823C (fr) * 2002-02-28 2011-02-22 Sanofi-Synthelabo Derives de 2-pyridinyl- et 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one subtituee par heteroaryle
AR053358A1 (es) * 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk
WO2008148074A2 (fr) * 2007-05-24 2008-12-04 Research Foundation Of State University Of New York Inhibiteurs de mtor et methodes de traitement mettant en œuvre ces inhibiteurs

Also Published As

Publication number Publication date
FR2947551A1 (fr) 2011-01-07

Similar Documents

Publication Publication Date Title
MA28941B1 (fr) Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
EA201290147A1 (ru) Пирроло[2,3-d]пиримидиновые соединения
FR2954317B1 (fr) Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
FR2954315B1 (fr) Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
UY32059A (es) Compuestos de pirrolo [2,3-d] pirimidina
EP2540720A4 (fr) Dérivé de 1,3,4,8-tétrahydro-2h-pyrido[1,2-a]pyrazine et son utilisation comme inhibiteur d'intégrase de vih
LT2658844T (lt) Nauji pirimidino dariniai, jų gamyba ir jų farmacinis panaudojimas kaip akt (pkb) fosforilinimo slopiklių
UY33503A (es) Imidazo [1,2-a]pirimidinas y piridinas sustituidas
EP2608669A4 (fr) Nouveaux dérivés de pyrazolo[1,5-a]pyrimidine utilisés comme inhibiteurs de mtor
BRPI1012697A2 (pt) derivados imidazo[1,2-a]piridina substituídos, composições farmacêuticas, e métodos de uso como inibidores da b-secretase
FR2992314B1 (fr) Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
WO2010068292A8 (fr) Dérivés d'azaindole en tant qu'inhibiteurs de kinases
FR2896503B1 (fr) Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
WO2011150201A3 (fr) Composés azolylamide et leurs procédés d'utilisation
IL217293A (en) Annotations of 9,8,7,6-tetrahydropyrimido {{a-2,1 pyramidine-4-one)
FR2896504B1 (fr) Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
FR2960876B1 (fr) Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
FR2969611B1 (fr) Nouveaux derives de thiazoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb)
FR2868422B1 (fr) Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
FR2947551B1 (fr) Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a)pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb)
FR2951174B1 (fr) Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb)
FR2951173B1 (fr) Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb)
FR2947550B1 (fr) Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt (pkb)
FR2969612B1 (fr) Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one, leur preparation et leur utilisation pharmaceutique
FR2951169B1 (fr) Nouveaux derives de (6-oxo-1,6-dihydro-pyrimidin-2-yl)-amide, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20170331